WASHINGTON, D.C. December 19, 2025 – President Donald J. Trump has announced significant progress in implementing “Most Favored Nation” (MFN) pricing policies aimed at reducing costs for American patients, according to a fact sheet released by the White House.
The initiative seeks to ensure that U.S. patients pay no more for prescription drugs and certain medical services than patients in other developed countries. In a related statement shared on social media, President Trump emphasized his intent to confront major insurance companies directly, saying: “I’m going to call a meeting of the big insurance companies that have gotten so rich… and I’m going to see if they get their price down, to put it very bluntly.”
The White House described the developments as the “largest to date” in bringing MFN pricing to American patients. The policy builds on previous executive efforts to align U.S. drug prices with those negotiated in nations with more centralized healthcare systems, potentially saving billions for consumers and taxpayers.
Supporters hailed the announcement as a major win for healthcare affordability, with some online reactions calling it the “biggest news in health care affordability ever.” Critics in past debates have raised concerns about potential impacts on pharmaceutical innovation and access, though the latest fact sheet focuses on protections for patients.
The full details are available in the official White House fact sheet: [Fact Sheet: President Donald J. Trump Announces Largest Developments to Date in Bringing Most-Favored-Nation Pricing to American Patients](https://www.whitehouse.gov/fact-sheets/2025/12/fact-sheet-president-donald-j-trump-announces-largest-developments-to-date-in-bringing-most-favored-nation-pricing-to-american-patients/).
This move comes as the administration prioritizes lowering healthcare costs, a key promise from President Trump’s campaign and previous term. Further meetings with insurance executives are expected in the coming weeks.
About The Author
